ArticleClinical ophthalmology (Auckland, N.Z.)2026
A Novel Microbubble Air Injection System for Controlled Graft Fixation in DMEK Surgery.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To describe a novel, low-cost microbubble air injection system using a customized 3-French nasogastric tube for precise volume control and stable graft fixation during Descemet membrane endothelial keratoplasty (DMEK). Design: Retrospective, single-surgeon observational study. Methods: A total of 80 eyes of 80 patients who underwent DMEK surgery between 2021 and 2025 were included. All procedures were performed by a single corneal specialist with more than 15 years of corneal surgical experience and approximately 5 years of DMEK experience. The system consisted of a standard 27-gauge anterior-chamber cannula connected to a short segment of 3-French nasogastric tubing. Technical success was defined as generation and intracameral delivery of a microbubble sufficient to complete the intended graft-positioning/fixation maneuver without conversion to conventional syringe-based air injection. Device-related intraoperative complications, conversion, rebubbling, elevated intraocular pressure (IOP), primary graft failure, graft rejection, best-corrected visual acuity (BCVA), central corneal thickness (CCT), and postoperative endothelial cell density (ECD) were reviewed. Results: Mean age was 65.8 ± 12.3 years. Fuchs endothelial corneal dystrophy accounted for 49 eyes (61.3%); 60 eyes (75.0%) underwent triple DMEK. Technical success was achieved in 80/80 eyes, with no conversion to a conventional syringe and no documented device-related intraoperative complication. Mean BCVA improved from 1.05 ± 0.61 to 0.43 ± 0.42 logMAR and mean CCT decreased from 630 ± 86.3 to 533.9 ± 55.8 µm. At 1 year, postoperative ECD was 1609 ± 563 cells/mm Conclusion: The novel microbubble air injection system is a feasible modification for DMEK surgery. Ergonomic customization based on the surgeon's hand size is critical for achieving optimal mechanical control, leading to successful graft fixation across diverse endothelial pathologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.